2023-509909-74-00
CTIS ↗
Kapruvia 50 micrograms/mL solution for injection
Pruritus, Chronic Kidney Diseases
pharma · Hypovolemia · Pruritus, Chronic Kidney Diseases
Fresenius Kabi Australia
Fresenius Kabi Australia Pty Limited
Fresenius Kabi Australia trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.
Mount Kuring-Gai, AU HQ
150 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Mount Kuring-Gai, AU
- Employees
- 150
- Programs
- 5
- Drugs
- 6
- Patents
- 0
Fresenius Kabi Australia clinical trials
Registry index of 5 ClinicalTrials.gov studies linked to Fresenius Kabi Australia programs — each row shows trial ID, program name, phase, status, and indication.
Fresenius Kabi Australia trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Fresenius Kabi Australia.
-
Kapruvia 50 micrograms/mL solution for injection — Phase 2
Clinical update -
6% hydroxyethyl starch 130/0.4 — Phase 3
Clinical update -
MSB11455 — Phase 1
Clinical update -
MSB11456 — Phase 1
Clinical update -
Comparison of Prefilled syringe and Autoinjector presentations of FYB202 — Phase 1
Clinical update
Trial registry
-
- 2025-522422-13-00CTIS ↗
Comparison of Prefilled syringe and Autoinjector presentations of FYB202
Chronic inflammatory diseases
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗